Notices and Disclosures Regarding Toxic Materials Sample Clauses

Notices and Disclosures Regarding Toxic Materials. Pursuant to H&S Code Section 25359.7, the Port notifies the Permittee that the Port has reasonable cause to believe that Toxic Materials have come to be located on, at, beneath or emanating from the Premises. This information includes, without limitation, the following reports:
AutoNDA by SimpleDocs
Notices and Disclosures Regarding Toxic Materials. Pursuant to H&S Code Section 25359.7, the Port notifies the Permittee that the Port has reasonable cause to believe that Toxic Materials have come to be located on, at, beneath or emanating from the Premises. Information regarding the Toxic Materials on the Premises may be included in reports available on DTSC’s Envirostor Website xxxx://xxx.xxxxxxxxxx.xxxx.xx.xxx/public/, the RWQCB’s Geotracker Website xxxx://xxxxxxxxxx.xxxxxxxxxxx.xx.xxx/, or Alameda County’s ftp site xxxx://xxx.xxxxx.xxx/MAPS/deh/InspectionResults/?SITE=LOP. In addition, the Permittee may request any non-privileged Toxic Material reports concerning the Premises that are in the possession of the Port.
Notices and Disclosures Regarding Toxic Materials. Pursuant to H&S Code Section 25359.7, the Port notifies Permittee that Toxic Materials have come to be located on, at, beneath or emanating from the Premises and other Port property. Permittee acknowledges that prior to execution of the Agreement, the Port has given to Permittee written notice, based on the Port’s commercially reasonable efforts, of the final non- privileged reports, which reports are listed in attached Exhibit-2 and by this reference incorporated herein, relating to the presence of Toxic Materials on, at, beneath or emanating from the Premises. Permittee shall provide notice as required by H&S Code Section 25359.7 or other applicable Law to Permittee Representatives, employees, contractors, licensees, invitees, or agents of such Toxic Materials. The Port accepts no liability for ensuring that Xxxxxxxxx’s Representatives, employees, contractors, licensees, invitees, or agents, including those conducting testing, construction and maintenance activities on the Premises, are satisfactorily protected from residual contaminants provided in 29 Code of Federal Regulations. Permittee shall assess all human health risks from vapor transport or direct contact with residual Toxic Materials or contaminants and incorporate such engineering and institutional controls as may be required to sufficiently protect the human health of onsite Permittee Representatives, employees, contractors, licensees, invitees, agents, and transient visitors. Permittee hereby waives any Action, or potential Action, related to Permittee Representative, employee, contractor, licensee, invitee, agent or visitor exposure or alleged exposure to any residual onsite Toxic Materials and shall indemnify, defend and hold harmless the Indemnitees in accordance with Section 8 from and against any and all such Actions, or potential Actions.

Related to Notices and Disclosures Regarding Toxic Materials

  • Publicity and Disclosures No press releases or public disclosure, either written or oral, of the transactions contemplated by this Agreement, shall be made by a party to this Agreement without the prior knowledge and written consent of Buyer and the Company.

  • UPDATING AND DISCLOSING FINANCIAL INFORMATION You will provide facts to update information contained in Your original Account application or other financial information related to You, at Our request. You also agree that We may, from time to time, as We deem necessary, make inquiries pertaining to Your employment, credit standing and financial responsibility in accordance with applicable laws and regulations. You further agree that We may give information about the status and payment history of Your Account to consumer credit reporting agencies, a prospective employer or insurer, or a state or federal licensing agency having any apparent legitimate business need for such information.

  • Permitted Uses and Disclosures of PHI 2.1 Unless otherwise limited herein, Business Associate may:

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • General Use and Disclosure Provisions Except as otherwise limited in this Section of the Contract, Business Associate may use or disclose PHI to perform functions, activities, or services for, or on behalf of, Covered Entity as specified in this Contract, provided that such use or disclosure would not violate the HIPAA Standards if done by Covered Entity or the minimum necessary policies and procedures of the Covered Entity.

  • Specific Use and Disclosure Provisions (A) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate.

  • Permitted Uses and Disclosures i. Business Associate shall use and disclose PHI only to accomplish Business Associate’s obligations under the Contract.

  • Confidentiality and Disclosure The Local Manager and the Investment Adviser undertake to keep private and confidential all information acquired in connection with this Agreement, and not to disclose such information to any person except to the extent that:

  • Use and Disclosure Restrictions Neither party shall, without the written consent of the other, communicate confidential information of the other, designated in writing or identified in this Agreement as such, to any third party and shall protect such information from inadvertent disclosure to any third party in the same manner that the receiving party would protect its own confidential information. The foregoing obligations will not restrict either party from disclosing confidential information of the other party: (a) pursuant to applicable law; (b) pursuant to the order or requirement of a court, administrative agency, or other governmental body, on condition that the party required to make such a disclosure gives reasonable written notice to the other party to contest such order or requirement; and (c) on a confidential basis to its legal or financial advisors.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Information disclosed to it by the other Party to the extent such use or disclosure: (i) is reasonably necessary in complying with Applicable Laws or otherwise submitting information to tax or other governmental authorities, (ii) is provided by the receiving Party to Third Parties, on a strictly as-needed basis, for consulting services, conducting Preclinical or Clinical Development, CMC/Process Development, Manufacturing, external testing, market research, or otherwise exercising its rights or performing its obligations hereunder; provided, that such Third Parties are obligated to maintain the confidentiality of such other Party’s Information as set forth herein for the benefit of such other Party for a period of at least the term of the agreement with such Third Party and for a period of *** thereafter; (iii) is included in submissions by the receiving Party to Governmental Authorities to facilitate the issuance of approvals for NDAs and NDA Equivalents for the Product, provided that reasonable measures shall be taken to assure confidential treatment of such Information; or (iv) is to Third Parties in connection with a receiving Party’s efforts to secure financing or enter into strategic partnerships, provided such Information is disclosed only on a need-to-know basis and under confidentiality provisions at least as stringent as those in this Agreement. Additionally, Bayer may disclose to Mitsui any Information received from Licensee hereunder; provided, that such disclosure is reasonably considered by Bayer to be necessary to comply with the terms and conditions of the Patent License Agreement; and further provided, that Mitsui is obligated to maintain the confidentiality of Licensee’s Information as set forth herein for the benefit of Licensee. Notwithstanding the foregoing, if a receiving Party is required to make any such disclosure of the disclosing Party’s confidential Information, other than pursuant to a confidentiality agreement, the receiving Party will give reasonable advance notice to the disclosing Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable efforts to secure confidential treatment of such Information prior to its disclosure (whether through protective orders or otherwise).

Time is Money Join Law Insider Premium to draft better contracts faster.